Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

c-MYC overexpression in Ba/F3 cells simultaneously elicits genomic instability and apoptosis

Abstract

Overexpression of c-Myc in tumors is usually associated with cell proliferation and increased susceptibility to apoptosis. Concomitantly, c-Myc contributes to tumorigenesis by its ability to destabilize the cellular genome. Here, we examined whether c-Myc induces genomic instability and apoptosis in c-Myc-activated cells. Wild-type Myc (wt-Myc) and two mutated Myc myc box II proteins (mt-Myc) were overexpressed in IL3-dependent murine Ba/F3 cells. As expected, wt-Myc triggered apoptosis in absence of IL3. Standard karyotyping, spectral karyotyping, and fluorescent in situ hybridization (FISH) were performed before and after c-Myc activation. Structural and numerical genomic instability was detected 48 h after wt-Myc activation and included gene amplification, the formation of extrachromosomal elements (EEs), chromosome breakage, deletions, increased aneuploidy, and polyploidization. Interestingly, some cells simultaneously displayed genomic instability and apoptosis. Both wt- and mt-Myc proteins were equally potent promoters of genomic instability. However, only wt-Myc simultaneously induced genomic instability and apoptosis. Mt-Myc proteins failed to induce apoptosis, thereby generating a strong imbalance towards the survival of genomically unstable cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 8
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Askew DS, Ashmun RA, Simmons BC, Cleveland JL . 1991 Oncogene 6: 1915–1922

  • Bhatia K, Gutierrez M, Huppi K, Siwarski D, Magrath I . 1992 Cancer Res. 52: 4273–4276

  • Brough DE, Hofmann TJ, Ellwood KB, Townley RA, Cole MD . 1995 Mol. Cell. Biol. 15: 1536–1544

  • Cheng KC, Loeb LA . 1993 Adv. Cancer Res. 60: 121–156

  • Chernova OB, Chernov MV, Ishizaka Y, Agarwal ML, Stark GR . 1998 Mol. Cell. Biol. 18: 536–545

  • Committee on Standardized Genetic Nomenclature for Mice . 1969 Mouse News Letter 17: 481–487

  • Cross SM, Souchez CA, Morgan CA, Schimte MK, Ramel S, Idzerda RL, Raskind WH, Reid BJ . 1995 Science 267: 1353–1356

  • D'Cruz CM, Gunther EJ, Boxer RB, Hartman JL, Sintasath L, Moody SE, Cox JD, Ha SI, Belka GK, Golant A, Cardiff RD, Chodosh LA . 2001 Nat. Met. 7: 235–239

  • Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brocks M, Waters CM, Decin LZ, Hancock DC . 1993 Cell 65: 113–128

  • Evan G, Littlewood T . 1998 Science 281: 1317–1322

  • Felsher DW, Bishop JM . 1999a Mol. Cell 4: 199–207

  • Felsher DW, Bishop JM . 1999b Proc. Natl. Acad. Sci. USA 96: 3940–3944

  • van Gent DC, Hoeijmakers JHJ, Kanaar R . 2001 Nature Reviews 2: 196–206

  • Gaidano G, Ballerini P, Gong J, Inghirami G, Neri A, Newcomb E, Magrath I, Knowles D, Dalla-Favera R . 1991 Proc. Natl. Acad. Sci. USA 88: 5413–5417

  • Harrington EA, Bennett MR, Fanidi A, Evan GI . 1994 EMBO J. 13: 3286–3295

  • Henriksson M, Lüscher B . 1996 Ad. Cancer Res. 68: 109–182

  • Kuschak TI, Taylor CT, McMillan-Ward E, Israels S, Henderson DW, Mushinski JF, Wright JA, Mai S . 1999 Gene 238: 351–365

  • Kuttler F, Amé P, Clark H, Haughey C, Mougin C, Cahn J-Y, Dang CV, Raffeld M, Fest T . 2001 Oncogene 20: 6084–6094

  • Li Q, Dang CV . 1999 Mol. Cell. Biol. 19: 5339–5351

  • Littlewood TD, Hancock DC, Danielian PS, Parker MG, Evan GI . 1995 Nucleic Acids Res. 23: 1686–1690

  • Mai S . 1994 Gene 148: 253–260

  • Mai S, Fluri M, Siwarski D, Huppi K . 1996b Chromosome Res. 4: 365–371

  • Mai S, Hanley-Hyde J, Fluri M . 1996a Oncogene 12: 277–288

  • Mai S, Hanley-Hyde J, Rainey GJ et al . 1999 Neoplasia 1: 241–252

  • Minn AJ, Boise LH, Thompson CB . 1996 Genes Dev. 10: 2621–2631

  • Nghiem P, Park PK, Kim Y, Vaziri C, Schreiber SL . 2001 Proc. Natl. Acad. Sci. USA 98: 9092–9097

  • Ormerod MG . 1990 A Practical Approach Ormerod MG (ed) Oxford: IRL Press pp 69–87

    Google Scholar 

  • Stone J, DeLange T, Ramsay G, Jakobovits E, Bishop JM, Varmus H, Lee W . 1987 Mol. Cell. Biol. 7: 1697–1709

  • Wang HC, Federoff S . 1971 Nature 235: 52–54

  • Wiener F, Mai S . 2000 Technical Tips Online 1: 8: T0184

  • Yin XY, Grove L, Datta NS, Long MW, Prochownik EV . 1999 Oncogene 18: 1177–1184

Download references

Acknowledgements

We thank Dr T Littlewood (ICRF, London) for providing the pBpuro Myc-ERTM vector, Pr J-Y Cahn for its support. We thank Dr TI Kuschak for critical reading of this manuscript. Research conducted in France was supported by the Faculty of Medicine Besançon Research Development Fund, by grants from Fondation de France, Paris, and Léderlé SA, and Amgen SA pharmaceutical companies. V Mougey is supported by the Ministère de l'Emploi, Programme Emploi-Jeune and the Etablissement Français du Sang de Bourgogne-Franche Comté. Research conducted in Canada was supported by the Canadian Foundation of Innovation, CancerCare Manitoba, and NSERC.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sabine Mai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fest, T., Mougey, V., Dalstein, V. et al. c-MYC overexpression in Ba/F3 cells simultaneously elicits genomic instability and apoptosis. Oncogene 21, 2981–2990 (2002). https://doi.org/10.1038/sj.onc.1205274

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205274

Keywords

This article is cited by

Search

Quick links